Promoting patient compliance can spell new business
Promoting patient compliance can generate new business for community R.Ph.s
New COPD guidelines offer more specific suggestions
Thoracic society meeting sees the release of new guidelines for the treatment of chronic obstructive pulmonary disease.
Rural women are in special need of pharmaceutical care
Women living in rural areas are in special need of pharmaceutical care
Legal Q&A: When PBMs don't pay due to missing Rx info
This installment deals with the problem of physicians who don't enter their DEA number on their Rxs
Chains work to keep e-health information from prying eyes
HIPAA's security standards will take effect in about a year and pharmacists are starting to conduct a risk analysis to prepare for the new requirements
Article Index
2004 Index of Articles
Breaking News
Breaking News for June 7, 2004
Plastic vials come under FDA scrutiny for link to med errors
FDA holds meeting to study issue of plastic vials and their association with drug errors
Supermarket pharmacists get taste of food business
Overview of FMI Pharmacy meeting in Chicago, 2004
Supermarket pharmacy exec raises concerns over Medicare
John Fagan, vp Ahold, talks about the new Medicare Rx bill and Rx discount cards.
FDA to R.Ph.s: Add number for reporting ADEs
Pharmacy reacts to FDA proposal requiring MedWatch number to be listed on Rx and OTC drugs
No easy answer to counterfeit Rxs, lament regulators
Manufacturers and regulators will have a tough time battling drug counterfeiters
More drug companies offering freebies, other deals
New trend: Pharmaceutical companies offer freebies and money back guarantees on drugs
How to create the worst possible pharmacy
David Brushwood gives a tongue-in-cheek account of how to create the worst-possible pharmacy
Med error reporting not enough to improve safety, says prof
Reporting medication errors has not translated into safer systems of patient care, according to Bruce Lambert, Ph.D., University of Illinois at Chicago department of pharmacy practice.
AARP creates AWP Web site to track drug price increases
Seniors can compare drug price increases with the inflation rate on AARP's new Web site
USP Drug Safety Review: Similarities in products can lead to errors
Similarities in labeling/packaging can lead to dispensing errors
Hospital explores sharing risk with drug manufacturers
Lehigh Valley Hospital explores risk sharing contracts with pharma manufacturers
HIPAA Today: Conducting a risk analysis
How to prepare for the new security standards, which take effect next year
Urinary infections found undertreated in women
While urinary tract infections in women are the second most frequent reason antibiotics are prescribed for women, many ignore symptoms or don't take steps necessary to prevent infection.
Breaking News for May 17, 2004
FDA: Pancreatic enzyme drugmakers must submit NDA
Certain pancreatic drugs could be withdrawn from market unless their manufacturers go through NDA process
NACDS chairman urges chains to promote value of R.Ph.
Abstract of speech given by Mary Sammons at NACDS Annual Meeting 2004
With no letup in diet craze, carb out your territory pronto
Manufacturers keep churning out low carb entries that can be profitable for pharmacies
Should PBMs disclose their contracts? Here are pros, cons
AMCP meeting sees debate between two laywers on whether contracts are public or private information
Will Medicare law affect retirees' Rx benefits?
Arxcel Rx benefit research survey 2004
New Web site for comparing prices is confusing to many
As part of the Medicare discount card and Medicare drug benefit law, a new Web site is being established that compares drug prices
PBMs say their card discounts could beat expectations
PCMA launches new ad campaign about discount cards for Medicare beneficiaries
New Drug Checklist: Ketek
Ketek is a new antibiotic for treatment of infections in the lung and sinus.
Rx discount card sponsors heed OIG kickback warning
Community pharmacy groups sponsoring Medicare-approved Rx discount cards are seeking clarification of the HHS office of inspector general's warning that fees to pharmacists may be kickbacks.
